The startup plans to enhance accuracy across its biomarker models. Early adopters praise the clarity its reports provide. The new capital will accelerate product releases.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
